A First-in-Human Phase I/IIa Trial of Personalised Tumour-Trained Lymphocytes (pTTL) Derived From Regional Lymph Nodes for the Treatment of Colorectal Cancer
2:00 pm - Thursday 23rd July 2026
- Personalised Neoantigen-based cell therapy for solid tumours
- First in human trial NEOGAP-CRC-01
- Safety and early biomarkers data
